Stockscreener 앱 받기
0.00
100.00%
-0.5746
시간 외 거래:
.60
0.60
+
전일 마감가:
$0.5746
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$7.05M
수익:
$5.22M
순이익/손실:
$-17.89M
주가수익비율:
0.00
EPS:
-1.5
순현금흐름:
$-15.28M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$3.16
Kineta Inc Stock (KA) Company Profile
명칭
Kineta Inc
전화
(206) 378-0400
주소
7683 SE 27TH STREET, MERCER ISLAND
KA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KA
Kineta Inc
|
0.00 | 7.05M | 5.22M | -17.89M | -15.28M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.11 | 106.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.59 | 80.61B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
649.26 | 38.82B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
240.55 | 31.03B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
122.15 | 29.28B | 3.30B | -501.07M | 1.03B | -2.1146 |
Kineta Inc 주식(KA)의 최신 뉴스
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHYF, ML, HURA, KANT on Behalf of Shareholders - The Malaysian Reserve
$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the MergerML, HURA, KANT, VTS - AccessWire
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of TuHURA Biosciences, Inc.HURA - The Eastern Progress Online
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, ML, HURA, KANT on Behalf of Shareholders - The Malaysian Reserve
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ML, PDCO, HURA, KANT on Behalf of Shareholders - GlobeNewswire
TuHURA Biosciences, Inc. entered into a non-binding agreement to acquire Kineta, Inc. from Craig Philips and others for $30 million. - Marketscreener.com
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Kineta, Inc.KANT - PR Newswire
TuHURA Biosciences to Acquire Kineta - citybiz
KANT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Kineta, Inc. Is Fair to Shareholders - The Bakersfield Californian
HURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of TuHURA Biosciences, Inc. Is Fair to Shareholders - Business Wire
TuHURA Biosciences to Acquire Kineta, Inc. in 2025 - TipRanks
Kineta Merges with TuHURA to Enhance Cancer Treatment - TipRanks
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc. - Sacramento Bee
TuHURA Biosciences to Acquire Kineta, Adding Promising Phase 2 Cancer Immunotherapy to Pipeline - StockTitan
Kineta Announces New Research Agreement to Evaluate VISTA Biomarker Expression - StockTitan
Kineta and TuHURA Enter Acquisition Agreement - TipRanks
TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell... - Markets Insider
ARMISTICE CAPITAL, LLC Acquires New Stake in Kineta Inc - GuruFocus.com
Kineta Updates KVA12123 Clinical Results from Ongoing Phase 1/2 VISTA101 Study at Society for Immunotherapy of Cancer (2024) - The Manila Times
BioWorld Cancer Index continues to decline amid broader market gains - BioWorld Online
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.25% - MSN
Codexis to Report Third Quarter 2024 Financial Results on October 31 - The Manila Times
Delisting of Securities of Gamer Pakistan Inc.; Biotricity, Inc.; Zalatoris II Acquisition Corp.; Warrantee Inc.; Spectaire Holdings, Inc.; Centogene N.V.; DZS Inc.; Corner Growth Acquisition Corp. 2; Collective Audience, Inc.; Grom Social Enterprises Inc.; Fintech Ec - ForexTV.com
Kineta Announces Completion of Enrollment in the Monotherapy Arm of the VISTA-101 Phase 1 Clinical Study in Advanced Solid Tumors - The Manila Times
Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta - AsiaOne
Kineta Announces KVA12123 Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024 - The Manila Times
Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta’s VISTA blocking antibody Currently in Phase 1 - ForexTV.com
Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta's VISTA blocking antibody Currently in Phase 1 - The Manila Times
Kineta Inc (KA-Q) QuotePress Release - The Globe and Mail
United States shares lower at close of trade; Dow Jones Industrial Average down 0.25% - MSN
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.25% - MSN
Chemotherapy Induced Anemia Drug Industry Growth Factors, Applications, and Forecast by (2024-2034) - Daily News Mirror
Short Interest in Kineta, Inc. (NASDAQ:KA) Drops By 99.3% - Defense World
Chemotherapy Induced Peripheral Neuropathy Treatment Market Insights Discussed Regarding Report 2024: Size,... - WhaTech
Kineta shares to be delisted from Nasdaq By Investing.com - Investing.com Australia
Kineta shares to be delisted from Nasdaq - Investing.com
Kineta, Inc Transitioning from Nasdaq to OTC Markets - ForexTV.com
Kineta transitions from Nasdaq to OTC markets - TipRanks
KA’s Stochastic Averages Dip: Analyzing Kineta Inc’s Stock Performance - The InvestChronicle
Chemotherapy Induced Peripheral Neuropathy Treatment Market Size, Innovations Driving Market Evolution (2024-2034) – La Funcion mx - La Funcion mx
Closing Figures: Kineta Inc (KA)’s Negative Finish at 0.57, Down -30.69 - The Dwinnex
Bishop Kiengei’s ex hilariously asks him to throw daughter bash, tags his wife - Tuko.co.ke
NickelX Directors Bolster Investment Amid Compliance Update - TipRanks
StockNews.com Upgrades Kinross Gold (NYSE:KGC) to Strong-Buy - Defense World
Kinross Gold (NYSE:KGC) Sees Unusually-High Trading Volume - Defense World
Popular Asian fusion eatery closes permanently due to power outage issues - MSN
Kalana Ispat Limited IPO Opens On September 19, 2024 - ANI News
Specialty Insurer Kinsale Set To Keep Up Its Strong Growth (NYSE:KNSL) - Seeking Alpha
You might want to take a look at Kinross Gold Corp. (KGC) now - SETE News
'Footpath to nowhere' a recipe for disaster, says principal - Northern Advocate
Jefferies gives a Hold recommendation for Kinross Gold Corp. (KGC) - Knox Daily
Kineta Inc (KA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.08%
0.05%
자본화:
|
볼륨(24시간):